121 related articles for article (PubMed ID: 38644724)
21. Preoperative prediction of sentinel lymph node metastasis in breast cancer by radiomic signatures from dynamic contrast-enhanced MRI.
Liu C; Ding J; Spuhler K; Gao Y; Serrano Sosa M; Moriarty M; Hussain S; He X; Liang C; Huang C
J Magn Reson Imaging; 2019 Jan; 49(1):131-140. PubMed ID: 30171822
[TBL] [Abstract][Full Text] [Related]
22. Intratumoral and peritumoral CT-based radiomics for predicting the microsatellite instability in gastric cancer.
Chen X; Zhuang Z; Pen L; Xue J; Zhu H; Zhang L; Wang D
Abdom Radiol (NY); 2024 May; 49(5):1363-1375. PubMed ID: 38305796
[TBL] [Abstract][Full Text] [Related]
23. Intra- and Peritumoral Based Radiomics for Assessment of Lymphovascular Invasion in Invasive Breast Cancer.
Jiang W; Meng R; Cheng Y; Wang H; Han T; Qu N; Yu T; Hou Y; Xu S
J Magn Reson Imaging; 2024 Feb; 59(2):613-625. PubMed ID: 37199241
[TBL] [Abstract][Full Text] [Related]
24. Predicting programmed death-ligand 1 expression level in non-small cell lung cancer using a combination of peritumoral and intratumoral radiomic features on computed tomography.
Shiinoki T; Fujimoto K; Kawazoe Y; Yuasa Y; Kajima M; Manabe Y; Ono T; Hirano T; Matsunaga K; Tanaka H
Biomed Phys Eng Express; 2022 Feb; 8(2):. PubMed ID: 35051908
[TBL] [Abstract][Full Text] [Related]
25. Intra- and peritumoral radiomics for predicting malignant BiRADS category 4 breast lesions on contrast-enhanced spectral mammography: a multicenter study.
Zhang S; Shao H; Li W; Zhang H; Lin F; Zhang Q; Zhang H; Wang Z; Gao J; Zhang R; Gu Y; Wang Y; Mao N; Xie H
Eur Radiol; 2023 Aug; 33(8):5411-5422. PubMed ID: 37014410
[TBL] [Abstract][Full Text] [Related]
26. Predictive value of triple negative breast cancer based on DCE-MRI multi-phase full-volume ROI clinical radiomics model.
Qi X; Wang W; Pan S; Liu G; Xia L; Duan S; He Y
Acta Radiol; 2024 Feb; 65(2):173-184. PubMed ID: 38017694
[TBL] [Abstract][Full Text] [Related]
27. Radiomics analysis of intratumoral and different peritumoral regions from multiparametric MRI for evaluating HER2 status of breast cancer: A comparative study.
Zhou J; Yu X; Wu Q; Wu Y; Fu C; Wang Y; Hai M; Tan H; Wang M
Heliyon; 2024 Apr; 10(7):e28722. PubMed ID: 38623231
[TBL] [Abstract][Full Text] [Related]
28. Intratumoral and peritumoral radiomics for the pretreatment prediction of pathological complete response to neoadjuvant chemotherapy based on breast DCE-MRI.
Braman NM; Etesami M; Prasanna P; Dubchuk C; Gilmore H; Tiwari P; Plecha D; Madabhushi A
Breast Cancer Res; 2017 May; 19(1):57. PubMed ID: 28521821
[TBL] [Abstract][Full Text] [Related]
29. Multiregional Radiomic Signatures Based on Functional Parametric Maps from DCE-MRI for Preoperative Identification of Estrogen Receptor and Progesterone Receptor Status in Breast Cancer.
Zhong S; Wang F; Wang Z; Zhou M; Li C; Yin J
Diagnostics (Basel); 2022 Oct; 12(10):. PubMed ID: 36292247
[TBL] [Abstract][Full Text] [Related]
30. Investigation of the combination of intratumoral and peritumoral radiomic signatures for predicting epidermal growth factor receptor mutation in lung adenocarcinoma.
Kawazoe Y; Shiinoki T; Fujimoto K; Yuasa Y; Hirano T; Matsunaga K; Tanaka H
J Appl Clin Med Phys; 2023 Jun; 24(6):e13980. PubMed ID: 37002910
[TBL] [Abstract][Full Text] [Related]
31. Potential Antihuman Epidermal Growth Factor Receptor 2 Target Therapy Beneficiaries: The Role of MRI-Based Radiomics in Distinguishing Human Epidermal Growth Factor Receptor 2-Low Status of Breast Cancer.
Bian X; Du S; Yue Z; Gao S; Zhao R; Huang G; Guo L; Peng C; Zhang L
J Magn Reson Imaging; 2023 Nov; 58(5):1603-1614. PubMed ID: 36763035
[TBL] [Abstract][Full Text] [Related]
32. Prediction of Axillary Lymph Node Metastasis in Early-stage Triple-Negative Breast Cancer Using Multiparametric and Radiomic Features of Breast MRI.
Song SE; Woo OH; Cho Y; Cho KR; Park KH; Kim JW
Acad Radiol; 2023 Sep; 30 Suppl 2():S25-S37. PubMed ID: 37331865
[TBL] [Abstract][Full Text] [Related]
33. MRI Radiomic Features: Association with Disease-Free Survival in Patients with Triple-Negative Breast Cancer.
Kim S; Kim MJ; Kim EK; Yoon JH; Park VY
Sci Rep; 2020 Feb; 10(1):3750. PubMed ID: 32111957
[TBL] [Abstract][Full Text] [Related]
34. Multiparametric MRI-based intratumoral and peritumoral radiomics for predicting the pathological differentiation of hepatocellular carcinoma.
Liu HF; Wang M; Wang Q; Lu Y; Lu YJ; Sheng Y; Xing F; Zhang JL; Yu SN; Xing W
Insights Imaging; 2024 Mar; 15(1):97. PubMed ID: 38536542
[TBL] [Abstract][Full Text] [Related]
35. Intratumoral and peritumoral MRI-based radiomics prediction of histopathological grade in soft tissue sarcomas: a two-center study.
Zhang L; Yang Y; Wang T; Chen X; Tang M; Deng J; Cai Z; Cui W
Cancer Imaging; 2023 Oct; 23(1):103. PubMed ID: 37885031
[TBL] [Abstract][Full Text] [Related]
36. Development of an interpretable machine learning model for Ki-67 prediction in breast cancer using intratumoral and peritumoral ultrasound radiomics features.
Wang J; Gao W; Lu M; Yao X; Yang D
Front Oncol; 2023; 13():1290313. PubMed ID: 38044998
[TBL] [Abstract][Full Text] [Related]
37. Intratumoral and peritumoral radiomics analysis for preoperative Lauren classification in gastric cancer.
Wang XX; Ding Y; Wang SW; Dong D; Li HL; Chen J; Hu H; Lu C; Tian J; Shan XH
Cancer Imaging; 2020 Nov; 20(1):83. PubMed ID: 33228815
[TBL] [Abstract][Full Text] [Related]
38. Gd-EOB-DTPA-enhanced MRI radiomics to predict vessels encapsulating tumor clusters (VETC) and patient prognosis in hepatocellular carcinoma.
Yu Y; Fan Y; Wang X; Zhu M; Hu M; Shi C; Hu C
Eur Radiol; 2022 Feb; 32(2):959-970. PubMed ID: 34480625
[TBL] [Abstract][Full Text] [Related]
39. Integrating intratumoral and peritumoral radiomics with deep transfer learning for DCE-MRI breast lesion differentiation: A multicenter study comparing performance with radiologists.
Yu T; Yu R; Liu M; Wang X; Zhang J; Zheng Y; Lv F
Eur J Radiol; 2024 Jun; 177():111556. PubMed ID: 38875748
[TBL] [Abstract][Full Text] [Related]
40. Extensive peritumoral edema and brain-to-tumor interface MRI features enable prediction of brain invasion in meningioma: development and validation.
Joo L; Park JE; Park SY; Nam SJ; Kim YH; Kim JH; Kim HS
Neuro Oncol; 2021 Feb; 23(2):324-333. PubMed ID: 32789495
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
